Telescope Innovations (TELIF) Stock Analysis & Winston Score
Telescope Innovations Corp. is a small Canadian biotechnology company focused on using automation and artificial intelligence to speed up chemistry research. It builds robotic systems and software tools that help scientists run chemical experiments faster and more efficiently. Its main customers are pharmaceutical and chemical companies looking to discover new drugs or materials more quickly. The company earns revenue by selling its automated chemistry platforms and related services, though it is still in an early stage and generates very little profit — its gross margin is just over 2% and it is spending far more than it earns. Telescope operates primarily in Canada with a focus on North American markets. Its competitive edge lies in combining robotics with chemistry expertise, a niche area with few direct competitors. The key risk is that the company burns through cash quickly, and it will likely need to raise more money to fund operations until it can scale its technology into a sustainable business.
Winston Score: 21/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
Key Facts
Price: $0.32
Market Cap: $18M
Sector: Healthcare
Industry: Biotechnology
Exchange: Other OTC
